Boisson, one of the earliest and most recognizable names in the non-alcoholic (NA) beverage space, has announced that it is entering a new chapter with a renewed focus on long-term growth and community collaboration. In an effort to restructure its direct-to-consumer market strategy and usher the brand into its next phase of growth, the company […]

Blockmate Ventures Inc. Investor Presentation Update GlobeNewswire July 09, 2025 LONDON and AMSTERDAM, July 09, 2025 (GLOBE NEWSWIRE) — Blockmate Ventures Inc. (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company“) has released an Investor Presentation which will be presented to a range of sophisticated and wholesale investors over the coming weeks. The presentation

Trading resumes in: Company: Elixxer Ltd. TSX-Venture Symbol: ELXR.H All Issues: Yes Resumption (ET): 9:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees

Trading resumes in: Company: Elixxer Ltd. TSX-Venture Symbol: ELXR.H All Issues: Yes Resumption (ET): 9:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees

(NASDAQ:ARTL), SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological conditions, today announced the presentation of preclinical data in an osteaoarthritis (OA) pain model on its lead fatty acid

Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium ART26.12, a Novel FABP5 Inhibitor, Demonstrates Sustained Analgesic Effects Without Tolerance GlobeNewswire July 09, 2025 SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused

Trading resumes in: Company: Green Panda Capital Corp. TSX-Venture Symbol: GPCC.P All Issues: Yes Resumption (ET): 9:30 CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which

Magaya Corporation, the leading freight management platform for logistics service providers, today announced a successful close to the second quarter,with revenue base growth right on track for the second quarter and ahead of projections for the first half of the year. https://mma.prnewswire.com/media/2726735/EOQ2_2025.jpg “Uncertainty has become the new normal for logistics service providers,” said Gary Nemmers,

The EIFS Industry Members Association(EIMA) is spearheading a comprehensive initiative to develop a Product Category Rule (PCR), Life Cycle Assessment (LCA), and Environmental Product Declaration (EPD) for Exterior Insulation and Finish Systems (EIFS). In an unprecedented show of unity, 100% of American EIFS manufacturers – EIMA members and non-members alike – are participating in the

NEW YORK, NY / ACCESS Newswire / July 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has